Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Laura Parkkinen

OPDC Investigator

  • Senior Research Fellow

Dr Laura Parkkinen heads the Neuropathology arm of OPDC and has a team of one PhD student and one research scientist. Her group focuses on high-throughput studies relating common genomic variation with expression patterns of Parkinson's risk genes, proteins and subsequent burden of pathology in human post-mortem brain. In OPDC, she is working to establish whether regional/cell-type specific gene expression may underpin the selective neuronal vulnerability in Parkinson's. Her group is also trying to establish whether a-synuclein pathology in peripheral nervous tissues and in CSF can provide a simple, reliable diagnostic tool for Parkinson's to identify patients at the earliest pre-symptomatic stages as well as to monitor disease progression and the effects of potential neuroprotective therapies.